What You Should Know:
– Doccla, a London-based provider of virtual ward and remote patient monitoring services, announced raises $45.9M (£35M) Series B funding round led by Lakestar with participation from Elaia as well as existing Doccla investors General Catalyst (led 2022 Series A), Bertelsmann Investments, and Speedinvest.
– The investment will fuel Doccla’s expansion plans across Europe, particularly focusing on France and the DACH region (Germany, Austria, and Switzerland).
Building Upon UK Success
Doccla has established itself as a cornerstone of virtual ward services in the UK. Trusted by NHS Trusts across half of the NHS regions and recently partnered with Ireland’s HSE, the company has already monitored millions of patient days across Europe. The fresh funding will allow Doccla to capitalize on this success and replicate their model in other markets.
Doccla’s Vision: Transforming Healthcare Delivery
Doccla was founded by Martin Ratz, inspired by a gap he identified in patient care following his own heart attack. Doccla’s virtual wards allow for early patient discharge and remote monitoring, freeing up resources for healthcare providers while offering a more comfortable recovery environment for patients.
Proven Results and Data-Driven Approach
Studies reveal significant benefits associated with Doccla’s services, including a 63% reduction in A&E attendance and a 300% return on investment. Doccla’s end-to-end solution integrates virtual care, hardware/software, logistics, and comprehensive support, enabling 24/7 patient monitoring across 40 pathways. This proactive approach empowers medical staff to intervene before issues escalate, reducing emergency admissions and patient stress.
Beyond the UK: Expanding to France, Germany, and Beyond
Doccla’s success in the UK has paved the way for international expansion. Partnerships with Ireland’s HSE and local teams established in France and Germany demonstrate Doccla’s commitment to providing virtual ward solutions across Europe. By replicating their successful model and tailoring it to local regulations, Doccla seeks to revolutionize healthcare delivery across the continent.
“Doccla was founded to provide hospital-level care and support at home for multiple patient profiles across the acuity spectrum: enabling the early discharge of patients, as well as ensuring that for those with chronic care needs, hospital admission might be avoided in the first place. Technology-enabled virtual wards deliver great benefits for patients, who can recover at home, while freeing up resources for healthcare providers. Our work has proven immensely valuable to the UK’s National Health Service and we’re excited to scale our European operations. At the same time, we see exceptional upside potential for our services in the Life Sciences sector, and will continue to invest in our data science operations,” said Doccla Founder Martin Ratz.
